Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
PMV Pharmaceuticals, Inc
University of Chicago
Tubulis GmbH
Eli Lilly and Company
Betta Pharmaceuticals Co., Ltd.
Theravectys S.A.
Kidney Cancer Research Bureau
Perspective Therapeutics
VM Oncology, LLC
ITM Oncologics GmbH
Maastricht University Medical Center
LigaChem Biosciences, Inc.
Coordination Pharmaceuticals, Inc.
Turning Point Therapeutics, Inc.
Marengo Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
Cancer Research UK
Rapa Therapeutics LLC
Fudan University
Psivac Ltd
Vanderbilt-Ingram Cancer Center
Second Affiliated Hospital of Guangzhou Medical University
Innolake Biopharm
GeneMedicine Co., Ltd.